89 related articles for article (PubMed ID: 24403464)
1. A phase I study of concurrent chemoradiotherapy using oral s-1 for head and neck cancer.
Fujimoto Y; Kato S; Itoh Y; Naganawa S; Nakashima T
Anticancer Res; 2014 Jan; 34(1):209-13. PubMed ID: 24403464
[TBL] [Abstract][Full Text] [Related]
2. A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma.
Tsuji H; Kiba T; Nagata M; Inoue T; Yukawa H; Yamashita T; Shimode Y; Murata H; Nagata K; Tomoda K
Oncology; 2006; 71(5-6):369-73. PubMed ID: 17851262
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604).
Tahara M; Fuse N; Mizusawa J; Sato A; Nihei K; Kanato K; Kato K; Yamazaki K; Muro K; Takaishi H; Boku N; Ohtsu A
Cancer Sci; 2015 Oct; 106(10):1414-20. PubMed ID: 26250827
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
Tahara M; Minami H; Kawashima M; Kawada K; Mukai H; Sakuraba M; Matsuura K; Ogino T; Hayashi R; Ohtsu A
Cancer Sci; 2011 Feb; 102(2):419-24. PubMed ID: 21134076
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
Fujii M; Tomita K; Nishijima W; Tsukuda M; Hasegawa Y; Ishitoya J; Yamane H; Homma A; Tomita T
Jpn J Clin Oncol; 2010 Mar; 40(3):214-21. PubMed ID: 19934112
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of preoperative chemoradiation therapy with S-1 for low rectal cancer.
Funahashi K; Koike J; Shiokawa H; Ushigome M; Shimada H; Kaneko H; Terahara A
Hepatogastroenterology; 2014; 61(129):99-104. PubMed ID: 24895802
[TBL] [Abstract][Full Text] [Related]
7. Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
Harada H; Nishio M; Murakami H; Ohyanagi F; Kozuka T; Ishikura S; Naito T; Kaira K; Takahashi T; Horiike A; Nishimura T; Yamamoto N
Clin Lung Cancer; 2013 Jul; 14(4):440-5. PubMed ID: 23540866
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II trial of concurrent use of S-1 and radiation therapy for T2 glottic cancer.
Nakayama M; Hayakawa K; Okamoto M; Niibe Y; Ishiyama H; Kotani S
Jpn J Clin Oncol; 2010 Oct; 40(10):921-6. PubMed ID: 20495190
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma.
Sadahiro S; Suzuki T; Tanaka A; Okada K; Kamijo A; Murayama C; Akiba T; Nakayama Y
Oncology; 2011; 81(5-6):306-11. PubMed ID: 22156392
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
11. Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer.
Shinoto M; Shioyama Y; Sasaki T; Nakamura K; Ohura H; Toh Y; Higaki Y; Yamaguchi T; Ohnishi K; Atsumi K; Hirata H; Honda H
Am J Clin Oncol; 2011 Aug; 34(4):362-6. PubMed ID: 20686402
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of nedaplatin and S-1 treatment with concurrent radiotherapy in advanced head and neck cancer.
Hoshikawa H; Kishino T; Mori T; Indo K; Inamoto R; Akiyama K; Miyashita T; Mori N
Acta Otolaryngol; 2015 Jan; 135(1):103-8. PubMed ID: 25496182
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of nedaplatin prior to S-1 in patients with locally advanced head and neck squamous cell carcinoma.
Sato D; Kogashiwa Y; Tsukahara K; Yamauchi K; Kohno N
Chemotherapy; 2013; 59(4):314-8. PubMed ID: 24480865
[TBL] [Abstract][Full Text] [Related]
14. Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas.
Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Hirakawa A; Naganawa S
Asian Pac J Cancer Prev; 2018 May; 19(5):1195-1199. PubMed ID: 29801401
[TBL] [Abstract][Full Text] [Related]
15. A Phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for Stage III non-small cell lung cancer: WJTOG 3305.
Tada T; Chiba Y; Tsujino K; Fukuda H; Nishimura Y; Kokubo M; Negoro S; Kudoh S; Fukuoka M; Nakagawa K; Nakanishi Y
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):327-31. PubMed ID: 22079726
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or Larynx.
Taguchi T; Takahashi M; Nishimura G; Shiono O; Komatsu M; Sano D; Sakuma Y; Tanigaki Y; Kubota A; Taguri M; Hata M; Oridate N
Jpn J Clin Oncol; 2014 Dec; 44(12):1158-63. PubMed ID: 25267992
[TBL] [Abstract][Full Text] [Related]
17. Preoperative radiotherapy combined with S-1 for advanced lower rectal cancer: phase I trial.
Morimoto S; Shimada M; Kurita N; Sato H; Iwata T; Nishioka M; Yoshikawa K; Miyatani T; Kashihara H; Takasu C; Ikushima H
Hepatogastroenterology; 2012; 59(117):1428-32. PubMed ID: 22155856
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma.
Nomura T; Murakami R; Toya R; Teshima K; Nakahara A; Hirai T; Hiraki A; Nakayama H; Yoshitake Y; Ota K; Obayashi T; Yamashita Y; Oya N; Shinohara M
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1347-52. PubMed ID: 19628343
[TBL] [Abstract][Full Text] [Related]
19. A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer.
Ikeda M; Ioka T; Ito Y; Yonemoto N; Nagase M; Yamao K; Miyakawa H; Ishii H; Furuse J; Sato K; Sato T; Okusaka T
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):163-9. PubMed ID: 22677367
[TBL] [Abstract][Full Text] [Related]
20. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A
Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
